Literature DB >> 27841982

Sexually Transmitted Infections in the Context of HIV Disease: Clinical Implications.

Dana W Dunne1.   

Abstract

Universal screening and frequent retesting are required to reduce the burden of sexually transmitted infections in the HIV-infected population. Dual treatment is available for gonorrhea, expedited partner therapy is effective and legal in most states, sexually transmitted infection rates are high in the context of preexposure prophylaxis, and there is a continuing rise in rates of syphilis, particularly early neurosyphilis. This article summarizes a presentation by Dana W. Dunne, MD, FACP, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in New York, New York, in March 2016.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27841982      PMCID: PMC6148914     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  12 in total

1.  Infections missed by urethral-only screening for chlamydia or gonorrhea detection among men who have sex with men.

Authors:  Julia L Marcus; Kyle T Bernstein; Robert P Kohn; Sally Liska; Susan S Philip
Journal:  Sex Transm Dis       Date:  2011-10       Impact factor: 2.830

2.  Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.

Authors:  Matthew R Golden; William L H Whittington; H Hunter Handsfield; James P Hughes; Walter E Stamm; Matthew Hogben; Agnes Clark; Cheryl Malinski; Jennifer R L Helmers; Katherine K Thomas; King K Holmes
Journal:  N Engl J Med       Date:  2005-02-17       Impact factor: 91.245

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 4.  The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis.

Authors:  Fabian Yuh Shiong Kong; Sepehr N Tabrizi; Christopher Kincaid Fairley; Lenka A Vodstrcil; Wilhelmina M Huston; Marcus Chen; Catriona Bradshaw; Jane S Hocking
Journal:  J Antimicrob Chemother       Date:  2015-01-29       Impact factor: 5.790

5.  Brief Report: Gonorrhea and Chlamydia Testing Increasing but Still Lagging in HIV Clinics in the United States.

Authors:  Stephen A Berry; Khalil G Ghanem; William Christopher Mathews; Philip Todd Korthuis; Baligh R Yehia; Allison L Agwu; Christoph U Lehmann; Richard D Moore; Sara L Allen; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

6.  Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: implications for prevention interventions.

Authors:  Kenneth H Mayer; Timothy Bush; Keith Henry; Edgar T Overton; John Hammer; Jean Richardson; Kathy Wood; Lois Conley; John Papp; Angela M Caliendo; Pragna Patel; John T Brooks
Journal:  Sex Transm Dis       Date:  2012-01       Impact factor: 2.830

7.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Authors:  Jean-Michel Molina; Catherine Capitant; Bruno Spire; Gilles Pialoux; Laurent Cotte; Isabelle Charreau; Cecile Tremblay; Jean-Marie Le Gall; Eric Cua; Armelle Pasquet; François Raffi; Claire Pintado; Christian Chidiac; Julie Chas; Pierre Charbonneau; Constance Delaugerre; Marie Suzan-Monti; Benedicte Loze; Julien Fonsart; Gilles Peytavin; Antoine Cheret; Julie Timsit; Gabriel Girard; Nicolas Lorente; Marie Préau; James F Rooney; Mark A Wainberg; David Thompson; Willy Rozenbaum; Veronique Doré; Lucie Marchand; Marie-Christine Simon; Nicolas Etien; Jean-Pierre Aboulker; Laurence Meyer; Jean-François Delfraissy
Journal:  N Engl J Med       Date:  2015-12-01       Impact factor: 91.245

8.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Authors:  Jared M Baeten; Deborah Donnell; Patrick Ndase; Nelly R Mugo; James D Campbell; Jonathan Wangisi; Jordan W Tappero; Elizabeth A Bukusi; Craig R Cohen; Elly Katabira; Allan Ronald; Elioda Tumwesigye; Edwin Were; Kenneth H Fife; James Kiarie; Carey Farquhar; Grace John-Stewart; Aloysious Kakia; Josephine Odoyo; Akasiima Mucunguzi; Edith Nakku-Joloba; Rogers Twesigye; Kenneth Ngure; Cosmas Apaka; Harrison Tamooh; Fridah Gabona; Andrew Mujugira; Dana Panteleeff; Katherine K Thomas; Lara Kidoguchi; Meighan Krows; Jennifer Revall; Susan Morrison; Harald Haugen; Mira Emmanuel-Ogier; Lisa Ondrejcek; Robert W Coombs; Lisa Frenkel; Craig Hendrix; Namandjé N Bumpus; David Bangsberg; Jessica E Haberer; Wendy S Stevens; Jairam R Lingappa; Connie Celum
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

9.  Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women.

Authors:  Jill S Huppert; Joel E Mortensen; Jennifer L Reed; Jessica A Kahn; Kimberly D Rich; William C Miller; Marcia M Hobbs
Journal:  Clin Infect Dis       Date:  2007-06-06       Impact factor: 9.079

10.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

Authors:  Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill
Journal:  Lancet       Date:  2015-09-09       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.